Dr. Erika Petersen, a professor of neurosurgery and the director of Functional & Restorative Neurosurgery and Neuromodulation at the University of Arkansas for Medical Sciences in Little Rock, joins us today. She was also the lead investigator on the Senza PDN randomized controlled trial, a study recently published in JAMA Neurology that looked at a new treatment for painful diabetes-related neuropathy. She’s here to discuss her findings and discuss the HFX solution, a device that was just approved by the FDA in July 2021. Roughly 20-30% of people with diabetes-related peripheral neuropathy experience neuropathic pain, so this new device may offer the pain relief and improved quality of life some of your clients need. This episode and the participation of Dr. Erika Petersen are sponsored by Nevro, makers of the HFX Solution. Visit HFXforPDN.com to learn more.
Resources